Subscribe To
Virios therapeutics stock doubles as fibromyalgia program moves forward
Virios Therapeutics shares more than doubled after the biotechnology company announced that its proposed Phase 3 program featuring its lead developmen...
April 25, 2023, 10:48 am
What is going on with in8bio (inab) stock today?
In8bio (NASDAQ: INAB ) stock is on the move Tuesday as investors react to a recent rally and additional news from the biotechnology company. First off...
April 25, 2023, 9:36 am
Betterlife to present betr-001 preclinical data at the 2023 annual meeting of the society of biological psychiatry (sobp) in san diego, california
VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BE...
April 25, 2023, 8:00 am
Why legend biotech stock is having its best month yet
Legend biotech Corporation (NASDAQ: LEGN) is among the many healthcare names vying for a breakthrough i...
April 25, 2023, 7:01 am
Eclinical solutions market to reach valuation of usd 27 bn at cagr of 12.8% by 2032 – report by market.us
According to Market.us, the eClinical solutions market is set to experience a surge in demand, propelled by rising investments by pharmaceutical and <...
April 25, 2023, 6:38 am
The 7 best biotech stocks for personalized medicine investors
Personalized medicine stocks are hot right now. This form of medicine based on the particular genes, proteins, and other substances in a person's body...
April 25, 2023, 6:35 am
3 biotech stocks to watch after johnson & johnson's earnings beat
Investors have shown keen interest in biotech after Johnson & Johnson's (NYSE: JNJ ) impressive earning...
April 25, 2023, 6:00 am
Okyo pharma ready to kick off dry eye trial in the us
OKYO Pharma Ltd (LSE:OKYO, NASDAQ:OKYO), an ophthalmology-focused biotech, said has activated its first clinical trial site in the United States for ...
April 25, 2023, 2:28 am
Top biotech stocks for q2 2023: first gem is biontech
Top biotech Stocks For Q2 2023: First Gem Is BioNTech....
April 25, 2023, 2:01 am
Sana biotechnology to host research & development day
SEATTLE, April 24, 2023 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through ...
April 24, 2023, 8:05 pm
Alps' biotech etf sbio week's top performer
In a somewhat surprising turn, biotech and life sciences-focused ETFs were the driving themes in the la...
April 24, 2023, 5:48 pm
3 pharma stocks that could see a surge in demand in 2023
As 2023 unfolds, the pharmaceutical space is blossoming with new opportunities, sparking curiosity for those looking to buy some pharma stocks. With t...
April 24, 2023, 3:55 pm
3 biotech stocks to sell before they're 6 feet under
In a high-interest-rate environment, cash is king. All biotech companies will need to continue spending...
April 24, 2023, 2:37 pm
Best etf areas of last week
Wall Street offered a flat performance last week. Biotech, platinum and home building were some of the areas that won last week....
April 24, 2023, 2:28 pm
Arkg: smart idea for smart advancements in cancer treatment
The cancer treatment/immuno-oncology market is expansive and ripe with potential for long-term healthcare investors. Predictably, there are significan...
April 24, 2023, 1:42 pm
Is adaptive biotechnologies (adpt) stock outpacing its medical peers this year?
Here is how Adaptive Biotechnologies (ADPT) and Avanos Medical (AVNS) have performed compared to their sector so far this year....
April 24, 2023, 11:26 am
4 pharma, biotech stocks poised to beat q1 earnings estimates
We look at a few pharma/biotech companies, SNY, AMGN, REGN, ACAD, which are poised to beat on earnings ...
April 24, 2023, 9:53 am
Astria: biotech to watch with proof of concept established for hae
Astria: biotech To Watch With Proof Of Concept Established For HAE....
April 24, 2023, 8:10 am
Foghorn therapeutics stock slides 21% after fda puts partial clinical hold on cancer drug trial
Foghorn Therapeutics Inc.'s stock FHTX slid 21% in premarket trade Monday, after the biotech said the F...
April 24, 2023, 7:20 am
Iovance biotherapeutics to present at upcoming conferences
SAN CARLOS, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing nov...
April 24, 2023, 7:01 am